Jennifer Wilson, MD
Obstetrics & Gynecology · Denver, CONPI 1154686657
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $534 and has fallen 97.1% since, to $15 in 2025.
Across 129 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$501
- Astellas Pharma US Inc$220
- Hologic Sales And Service, LLC$193
- Daiichi Sankyo Inc.$190
- Bayer$142
- Mayne Pharma Commercial LLC$136
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,46899%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $501 |
| Astellas Pharma US Inc | 10 | $220 |
| Hologic Sales And Service, LLC | 6 | $193 |
| Daiichi Sankyo Inc. | 12 | $190 |
| Bayer | 8 | $142 |
| Mayne Pharma Commercial LLC | 7 | $136 |
| Therapeuticsmd, Inc. | 7 | $118 |
| Merck | 7 | $117 |
| Exeltis, USA Inc. | 4 | $90 |
| Lupin Inc. | 6 | $82 |
| Evofem Biosciences, Inc. | 4 | $64 |
| Pfizer | 3 | $58 |
| Exact Sciences | 2 | $51 |
| Baxter Healthcare | 1 | $50 |
| Organon | 3 | $48 |
| Coopersurgical, Inc. | 3 | $43 |
| Eisai Inc. | 2 | $36 |
| Shield Therapeutics Inc | 2 | $36 |
| Meditrina | 1 | $33 |
| AMAG Pharmaceuticals, Inc. | 2 | $32 |
| Aspira Women's Health Inc | 1 | $31 |
| Abbott | 1 | $26 |
| AstraZeneca | 1 | $25 |
| Medicem Inc. | 1 | $24 |
| Roche Diagnostics Corporation | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Avanos Medical | 1 | $18 |
| Alydia Health | 1 | $16 |
| Dysis Medical, Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $12 |
| Encision Inc | 1 | $12 |
How this compares
$2,500 in reported general payments places this provider in the 85th percentile of 705 obstetrics & gynecology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 17 | $3,467 |
| Trospium Chloride | 12 | $656 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Denver
- William BrownDenver$76K
- Kristina TocceDenver$57K
- Victor DabeleaDenver$18K
- Jeremiah BartleyDenver$15K
- Terry DunnDenver$15K
- Daniel JacobsonDenver$10K
- Bhavani ChillaraDenver$10K
- Natalia ArangoDenver$7K
- Lauren KauvarDenver$6K
- Sarah PayneDenver$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.